Stocks / VIR / Shares Outstanding

Vir Biotechnology, Inc. Shares Outstanding 2017–2025

Vir Biotechnology, Inc. reported 139.5M of shares outstanding for fiscal 2025. That was 1.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +9.5%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details.

Latest filed value
139.5M
One-year change
+1.8%
Change since 2020
+9.5%
Latest period end
2025-12-31
Vir Biotechnology, Inc. Shares Outstanding history from 2017 to 2025FY 2017: 0FY 2018: 8858799FY 2019: 107648925FY 2020: 127416740FY 2021: 131161404FY 2022: 133236687FY 2023: 134781286FY 2024: 136959446FY 2025: 139474954
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearShares OutstandingChange (YoY)
FY 2025139.5M+1.8%
FY 2024137.0M+1.6%
FY 2023134.8M+1.2%
FY 2022133.2M+1.6%
FY 2021131.2M+2.9%
FY 2020127.4M+18.4%
FY 2019107.6M+1115.2%
FY 20188.9M—
FY 20170.0M—

Source: Vir Biotechnology, Inc. SEC filings — balance sheet (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open VIR 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Vir Biotechnology, Inc. reported 139.5M of shares outstanding for fiscal 2025. That was 1.8% higher than fiscal 2024. Compared with fiscal 2020, the change was +9.5%. A rising share count can dilute per-share ownership; the filings should be checked for issuance and stock-compensation details. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Vir Biotechnology, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Vir Biotechnology, Inc. — frequently asked questions

What is Vir Biotechnology, Inc.'s shares outstanding?

Vir Biotechnology, Inc. (VIR) reported shares outstanding of 139.5M for fiscal year 2025, per its SEC filings.

Where does this data come from?

Figures are computed from Vir Biotechnology, Inc.'s official SEC filings (balance sheet (10-K), split-adjusted), refreshed nightly. Not investment advice.

More VIR financial history

VIR revenueVIR net incomeVIR gross profitVIR eps (earnings per share)VIR ebitdaVIR free cash flowVIR total debtVIR dividend historyVIR p/e ratio

Full VIR fundamentals page → · Analyze shares outstanding with a free tool → · Research guide & leaders → · All 1,500+ companies →